Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Targeting Protein-Protein Interactions by Small Molecules -

Targeting Protein-Protein Interactions by Small Molecules (eBook)

eBook Download: PDF
2018 | 1st ed. 2018
XI, 329 Seiten
Springer Singapore (Verlag)
978-981-13-0773-7 (ISBN)
Systemvoraussetzungen
96,29 inkl. MwSt
(CHF 93,95)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

This book comprehensively reviews the state-of-the-art strategies developed for protein-protein interaction (PPI) inhibitors, and highlights the success stories in new drug discovery and development. Consisting of two parts with twelve chapters, it demonstrates the design strategies and case studies of small molecule PPI inhibitors. The first part discusses various discovery strategies for small molecule PPI inhibitors, such as high throughput screening, hot spot-based design, computational approaches, and fragment-based design. The second part presents recent advances in small molecule inhibitors, focusing on clinical candidates and new PPI targets. This book has broad appeal and is of significant interest to the pharmaceutical science and medicinal chemistry communities. 




Chunquan Sheng is currently a Professor, Vice Dean of the School of Pharmacy and the Director of the Department of Medicinal Chemistry at Second Military Medical University (SMMU), P. R. China. He received his PhD degree in Medicinal Chemistry (2005) from SMMU and then worked at the Department of Medicinal Chemistry, School of Pharmacy at SMMU. His research interests include structure-based design and synthesis of drug-like molecules with an emphasis on small molecule inhibitors of protein-protein interactions and multi-targeting drugs. He has published more than 100 research articles and invited reviews in prestigious journals in the field of medicinal chemistry and holds more than 10 patents. He was supported by several programs, including the National Outstanding Young Scholarship from the National Natural Science Foundation of China (NSFC). 

Gunda I. Georg is Professor and Head of the Department of Medicinal Chemistry and the founding Director of the Institute for Therapeutics Discovery and Development (ITDD) at the University of Minnesota College of Pharmacy. She holds the Robert Vince Endowed Chair and the McKnight Presidential Chair in Medicinal Chemistry. She is the Co-Editor-in-Chief of the Journal of Medicinal Chemistry, the most cited journal in the field.  Dr. Georg received a BS in Pharmacy (1975) and a PhD degree in Medicinal Chemistry (1980) from the Philipps University of Marburg, Germany.  She was a postdoctoral fellow at the Department of Chemistry at the University of Ottawa in Canada.  After 22 years as a faculty member at the University of Kansas, she joined the University of Minnesota in 2007.  Her research focuses on the design, synthesis, and evaluation of biologically active agents.


This book comprehensively reviews the state-of-the-art strategies developed for protein-protein interaction (PPI) inhibitors, and highlights the success stories in new drug discovery and development. Consisting of two parts with twelve chapters, it demonstrates the design strategies and case studies of small molecule PPI inhibitors. The first part discusses various discovery strategies for small molecule PPI inhibitors, such as high throughput screening, hot spot-based design, computational approaches, and fragment-based design. The second part presents recent advances in small molecule inhibitors, focusing on clinical candidates and new PPI targets. This book has broad appeal and is of significant interest to the pharmaceutical science and medicinal chemistry communities. 

Chunquan Sheng is currently a Professor, Vice Dean of the School of Pharmacy and the Director of the Department of Medicinal Chemistry at Second Military Medical University (SMMU), P. R. China. He received his PhD degree in Medicinal Chemistry (2005) from SMMU and then worked at the Department of Medicinal Chemistry, School of Pharmacy at SMMU. His research interests include structure-based design and synthesis of drug-like molecules with an emphasis on small molecule inhibitors of protein–protein interactions and multi-targeting drugs. He has published more than 100 research articles and invited reviews in prestigious journals in the field of medicinal chemistry and holds more than 10 patents. He was supported by several programs, including the National Outstanding Young Scholarship from the National Natural Science Foundation of China (NSFC).  Gunda I. Georg is Professor and Head of the Department of Medicinal Chemistry and the founding Director of the Institute for Therapeutics Discovery and Development (ITDD) at the University of Minnesota College of Pharmacy. She holds the Robert Vince Endowed Chair and the McKnight Presidential Chair in Medicinal Chemistry. She is the Co-Editor-in-Chief of the Journal of Medicinal Chemistry, the most cited journal in the field.  Dr. Georg received a BS in Pharmacy (1975) and a PhD degree in Medicinal Chemistry (1980) from the Philipps University of Marburg, Germany.  She was a postdoctoral fellow at the Department of Chemistry at the University of Ottawa in Canada.  After 22 years as a faculty member at the University of Kansas, she joined the University of Minnesota in 2007.  Her research focuses on the design, synthesis, and evaluation of biologically active agents.

Part 1 Current strategies for the discovery of small-molecule inhibitors of protein–protein interactions.- Overview of Protein-protein Interactions and Small Molecule Inhibitors under Clinical Development.- High throughput screening in the discovery of small molecule inhibitors of protein-protein interactions.- Hot Spot-Based Design of Small-Molecule Inhibitors for Protein–Protein Interactions.- Computational Methods Applicable to the Discovery of Small-Molecule Inhibitors of Protein-Protein Interactions.- Experimental Methods Used for Identifying Small-Molecule Inhibitors of Protein-protein Interaction.- Fragment-based Drug Discovery for Developing Inhibitors of Protein-protein Interactions.- Part 2 Case studies of small-molecule inhibitors of protein–protein interactions.- Small molecule inhibitors targeting new targets of protein-protein interactions.- The Development of New Spirooxindoles Targeting the p53-MDM2 Protein-Protein Interactions for Cancer Therapy.- Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein−Protein Interaction.- Discovery and development of Keap1-Nrf2 protein-protein interaction inhibitors.- BRDT Inhibitors for Male Contraceptive Drug Discovery: Current Status.- Targeting Protein-Protein Interactions in Small GTPases.

Erscheint lt. Verlag 26.6.2018
Zusatzinfo XI, 329 p. 132 illus., 100 illus. in color.
Verlagsort Singapore
Sprache englisch
Themenwelt Medizin / Pharmazie Studium
Naturwissenschaften Biologie Biochemie
Naturwissenschaften Chemie Organische Chemie
Naturwissenschaften Chemie Physikalische Chemie
Technik
Schlagworte Fragment based drug discovery • high throughput screening • Hot Spots • Keap1-Nrf2 • p53-MDM2 • protein-protein interactions • Secondary structure mimetics • Small molecule inhibitors • β Catenin/T-Cell Factor
ISBN-10 981-13-0773-3 / 9811307733
ISBN-13 978-981-13-0773-7 / 9789811307737
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 12,8 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich

von Donald Voet; Judith G. Voet; Charlotte W. Pratt

eBook Download (2019)
Wiley-VCH Verlag GmbH & Co. KGaA
CHF 72,25

von Donald Voet; Judith G. Voet; Charlotte W. Pratt

eBook Download (2019)
Wiley-VCH Verlag GmbH & Co. KGaA
CHF 72,25